Financial Analysis: Mirum Pharmaceuticals Inc (MIRM)’s Ratios Unveil Key Insights

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Mirum Pharmaceuticals Inc’s stock clocked out at $31.14, up 6.46% from its previous closing price of $29.25. In other words, the price has increased by $6.46 from its previous closing price. On the day, 1.21 million shares were traded. MIRM stock price reached its highest trading level at $31.68 during the session, while it also had its lowest trading level at $28.6.

Ratios:

To gain a deeper understanding of MIRM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.47 and its Current Ratio is at 3.68. In the meantime, Its Debt-to-Equity ratio is 1.31 whereas as Long-Term Debt/Eq ratio is at 1.31.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on April 17, 2024, initiated with a Buy rating and assigned the stock a target price of $48.

On December 18, 2023, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $60 to $58.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 05 ’24 when Ramasastry Saira sold 5,000 shares for $25.68 per share. The transaction valued at 128,400 led to the insider holds 0 shares of the business.

BJERKHOLT ERIC bought 2,000 shares of MIRM for $49,600 on Mar 27 ’24. The CHIEF FINANCIAL OFFICER now owns 14,000 shares after completing the transaction at $24.80 per share. On Mar 25 ’24, another insider, Radovich Peter, who serves as the PRESIDENT AND COO of the company, sold 4,303 shares for $25.80 each. As a result, the insider received 111,017 and left with 29,013 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIRM now has a Market Capitalization of 1467721600 and an Enterprise Value of 1472400256. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.55 while its Price-to-Book (P/B) ratio in mrq is 6.25. Its current Enterprise Value per Revenue stands at 6.573 whereas that against EBITDA is -15.778.

Stock Price History:

The Beta on a monthly basis for MIRM is 1.13, which has changed by 0.138574 over the last 52 weeks, in comparison to a change of 0.2586832 over the same period for the S&P500. Over the past 52 weeks, MIRM has reached a high of $35.56, while it has fallen to a 52-week low of $23.14. The 50-Day Moving Average of the stock is 22.85%, while the 200-Day Moving Average is calculated to be 10.94%.

Shares Statistics:

It appears that MIRM traded 546.01K shares on average per day over the past three months and 1048750 shares per day over the past ten days. A total of 46.72M shares are outstanding, with a floating share count of 37.92M. Insiders hold about 19.55% of the company’s shares, while institutions hold 97.84% stake in the company. Shares short for MIRM as of 1715731200 were 8814571 with a Short Ratio of 16.29, compared to 1713139200 on 8575418. Therefore, it implies a Short% of Shares Outstanding of 8814571 and a Short% of Float of 21.78.

Most Popular